The Section of Hematology at Rush University Medical Center in Chicago offers compassionate, multidisciplinary care for people with a variety of benign blood disorders and cancers that develop in bone marrow, blood and lymph nodes, including:
The hematology team at Rush treats people with a variety of benign blood disorders and cancers that develop in the bone marrow, blood and lymph nodes through the following programs and centers:
We offer a full range of standard and innovative treatments, including less toxic chemotherapy options. Our facilities include an on-site pharmacy, a comfortable treatment area and a dedicated room for diagnostic bone marrow procedures. Our diagnostic bone marrow procedure lab oversees over 1,000 samples annually.
Because we are committed to finding new treatments and helping to improve patient outcomes, our clinical staff is involved in a number of ongoing research projects. For more information about our clinical trials, see our Cancer Clinical Trials page.
The Section of Hematology at Rush is also a leader in educating physicians regarding new developments and treatments in cancer and benign blood disorders. In collaboration with the Lymphoma Research Foundation, the physicians at Rush formed the Chicago Lymphoma Club, which brings together all academic medical centers and community oncologists to discuss treatment advances and best practices. Additionally, the Section hosts a yearly medical education event for physicians to review the major advances discussed at the American Society of Hematology meeting.